Log In
Print
BCIQ
Print
Print this Print this
 

Meganucleases

  Manage Alerts
Collapse Summary General Information
Company Cellectis S.A.
DescriptionSingle-chain meganulceases targeting herpes simplex virus type 1 (HSV-1)
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationHerpes simplex virus (HSV)
Indication DetailsTreat herpes simplex virus type 1 (HSV-1) infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today